Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline
- PMID: 19254666
- DOI: 10.1016/j.cardfail.2009.01.006
Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline
Abstract
Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.
Comment in
-
Familial amyloid cardiomyopathy due to TTR mutations: an underdiagnosed cause of restrictive cardiomyopathy [corrected].J Card Fail. 2009 Jun;15(5):464. doi: 10.1016/j.cardfail.2009.04.003. J Card Fail. 2009. PMID: 19477408 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical